Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3299-3303

  Duan, Xiao Li ^a   Gong, Heng ^a   Zeng, Xian Tao ^a   Ni, Xiao Bing ^a   Yan, Yan ^a   Chen, Wen ^a   Liu, Guo Lei ^a  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Esophageal cancer; Excision repair; Meta analysis; Polymorphism; Susceptibility; XPD

Indexed keywords

EID: 84873608075     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3299     Document Type: Article

References (28)

1. Borenstein M, Hedges L, Rothstein H (2005) Comprehensive Meta-analysis. Version 2 ed. Biostat, Englewood, New Jersey.
2. Brown LM, Devesa SS, Chow WH (2008). Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst, 100, 1184-7.
3. Cleaver JE, Thompson LH, Richardson AS, et al (1999). A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Hum Mutat, 14, 9-22.
4. Coin F, Marinoni JC, Rodolfo C, et al (1998). Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat Genet, 20, 184-8.
5. Ding DP, Ma WL, He XF, et al (2012). XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta- analysis of case-control studies. Mol Biol Rep, 39, 2533-40.
6. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
7. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
8. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
9. Hoeijmakers JH (2001). Genome maintenance mechanisms for preventing cancer. Nature, 411, 366-74.
10. Huang CG, Liu T, Lv GD, et al (2012). Analysis of XPD genetic polymorphisms of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China. Mol Biol Rep, 39, 709-14.
11. Lea IA, Jackson MA, Li X, et al (2007). Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns. Carcinogenesis, 28, 1851-8.
12. Liu G, Zhou W, Yeap BY, et al (2007). XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Carcinogenesis, 28, 1254-8.
13. Mayne ST, Risch HA, Dubrow R, et al (2001). Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev, 10, 1055-62.
14. Moher D, Liberati A, Tetzlaff J, et al (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, b2535.
15. Pan J, Lin J, Izzo JG, et al (2009). Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis, 30, 785-92.
16. Shen MR, Jones IM, Mohrenweiser H (1998). Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res, 58, 604-8.
17. Szumilo J (2009). Epidemiology and risk factors of the esophageal squamous cell carcinoma. Pol Merkur Lekarski, 26, 82-5.
18. Tse D, Zhai R, Zhou W, et al (2008). Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk. Cancer Causes Control, 19, 1077-83.
19. Umar SB, Fleischer DE (2008). Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol, 5, 517-26.
20. Vaughan TL, Davis S, Kristal A, et al (1995). Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev, 4, 85-92.
21. Wood RD, Mitchell M, Sgouros J, et al (2001). Human DNA repair genes. Science, 291, 1284-9.
22. Xing D, Qi J, Miao X, et al (2002). Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Cancer, 100, 600-5.
23. Xing DY, Qi J, Tan W, et al (2003). Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 20, 35-8.
24. Xu XC (2009). Risk factors and gene expression in esophageal cancer. Methods Mol Biol, 471, 335-60.
25. Ye W, Kumar R, Bacova G, et al (2006). The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden. Carcinogenesis, 27, 1835-41.
26. Yu HP, Wang XL, Sun X, et al (2004). Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma. Cancer Genet Cytogenet, 154, 10-5.
27. Yuan L, Cui D, Zhao EJ, et al (2011). XPD Lys751Gln polymorphism and esophageal cancer risk: a meta-analysis involving 2288 cases and 4096 controls. World J Gastroenterol, 17, 2343-8.
28. Zheng S, Vuitton L, Sheyhidin I, et al (2010). Northwestern China: a place to learn more on oesophageal cancer. Part one: behavioural and environmental risk factors. Eur J Gastroenterol Hepatol, 22, 917-25.